Related Experiment Video
Updated: May 30, 2026
09:48
Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
Ectopic fat storage, insulin resistance, and hypertension
Anna Maria Sironi1, Rosa Sicari, Franco Folli
1Institute of Clinical Physiology, National Research Council, Pisa Italy.
Current Pharmaceutical Design
|August 25, 2011
Summary
Obesity and metabolic syndrome increase risks for cardiovascular disease, diabetes, and hypertension. Managing obesity through lifestyle or medical interventions is key for preventing and treating high blood pressure and improving glucose metabolism.
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
- Endocrinology
Background:
- Metabolic syndrome, characterized by obesity, insulin resistance, and hypertension, is a major risk factor for cardiovascular diseases, kidney failure, and cancer.
- Ectopic fat accumulation (mediastinal, hepatic, abdominal) and generalized obesity are linked to both systolic and diastolic arterial hypertension.
- Obesity activates multiple pathways contributing to hypertension, including insulin resistance, inflammation, Renin-Angiotensin-Aldosterone System (RAAS) activation, oxidative stress, and autonomic dysregulation.
Purpose of the Study:
- To explore the intricate relationship between obesity, metabolic syndrome, and arterial hypertension.
- To elucidate the mechanisms linking obesity to hypertension and impaired glucose metabolism.
- To highlight the therapeutic potential of targeting obesity for cardiovascular and metabolic health.
Main Methods:
- Review of existing literature on obesity, metabolic syndrome, and hypertension.
- Analysis of pathophysiological mechanisms connecting ectopic fat, systemic inflammation, RAAS, and oxidative stress to arterial hypertension.
- Examination of the impact of obesity management strategies on blood pressure and glucose metabolism.
Main Results:
- Obesity is a central driver of metabolic syndrome, contributing to insulin resistance, glucose intolerance, and arterial hypertension.
- Multiple interconnected mechanisms, including RAAS activation and inflammation, mediate the hypertensive effects of obesity.
- Pharmacological interventions targeting the RAAS, such as ACE inhibitors and ATII receptor blockers, demonstrate benefits for both hypertension and glucose metabolism.
Conclusions:
- Obesity is a critical, modifiable risk factor for metabolic syndrome and its associated complications, including hypertension and type 2 diabetes.
- Effective strategies for obesity prevention and treatment, encompassing dietary, medical, and surgical approaches, are fundamental for managing arterial hypertension and improving metabolic health.
- Targeting obesity offers a promising avenue for the primary prevention and treatment of cardiovascular and cerebrovascular diseases.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...